A Multicenter Cancer Biospecimen Collection Study
|
A. Dimitrios Colevas, MD
|
Recruiting
|
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
|
Saad A. Khan, MD
|
Recruiting
|
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
|
Michael Gensheimer
Quynh-Thu Le, MD
Michael J. Kaplan, MD
A. Dimitrios Colevas, MD
|
Recruiting
|
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
|
|
Recruiting
|
Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
|
Chris Holsinger, MD, FACS
Michelle M. Chen, MD, MHS
|
Recruiting
|
Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer
|
A. Dimitrios Colevas, MD
|
Recruiting
|
Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
|
|
Recruiting
|
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
|
Chris Holsinger, MD, FACS
|
Recruiting
|
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
|
Quynh-Thu Le, MD
John B. Sunwoo, MD
Harlan Pinto
Billy W Loo, Jr, MD PhD FASTRO FACR
|
Recruiting
|
Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia
|
Dyani Gaudilliere
|
Recruiting
|
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
|
Zijie Sun
Quynh-Thu Le, MD
Peter H. Hwang, MD
John B. Sunwoo, MD
Michael J. Kaplan, MD
Willard ("Bill") E. Fee, Jr., MD
|
Recruiting
|
Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
|
Beth Beadle
|
Recruiting
|
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
|
Nataliya Kovalchuk
Quynh-Thu Le, MD
Beth Beadle
|
Recruiting
|
d-Limonene +Radiation +Platinum Based Chemo for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma
|
Quynh-Thu Le, MD
|
Recruiting
|
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
|
Hanlee P. Ji
James Ford
|
Recruiting
|
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
|
Nataliya Kovalchuk
Fred M Baik, MD
|
Recruiting
|
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
|
Peter H. Hwang, MD
Saad A. Khan, MD
|
Recruiting
|
Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies
|
A. Dimitrios Colevas, MD
|
Recruiting
|
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
|
A. Dimitrios Colevas, MD
|
Recruiting
|